Vagus nerve stimulation and pulmonary outcomes: a scoping review of preclinical and clinical evidence
- 1 July 2026
- journal article
- review article
- Published by Springer Nature in Clinical Autonomic Research
- Vol. 36 (4) , 1-10
Abstract
Background Vagus nerve stimulation (VNS) is a neuromodulatory intervention with antiinflammatory and autonomic regulatory properties. Although its clinical applications have primarily been explored in neurological disorders, its potential role in pulmonary and respiratory outcomes across preclinical and clinical settings remains incompletely characterized and dispersed across different study domains. This scoping review aimed to map the available evidence on the effects of VNS on the pulmonary and respiratory systems, with particular emphasis on inflammatory and autonomic mechanisms. Methods This scoping review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. Three reviewers systematically searched PubMed, Web of Science, and the Cochrane Library for studies published between January 2020 and February 2026. Original preclinical and clinical studies investigating invasive or noninvasive VNS and reporting pulmonary, respiratory physiology, autonomic, or inflammatory outcomes were included. Results A total of 159 records were identified, of which 12 studies met the inclusion criteria. The evidence base was predominantly preclinical. In animal studies, invasive cervical VNS was frequently associated with reductions in pulmonary inflammation, histopathological lung injury, and proinflammatory cytokine expression. Clinical studies were limited and heterogeneous, but generally indicated variable modulation of autonomic function, including changes in parasympathetic activity, as well as heterogeneous effects on systemic inflammatory markers and limited respiratory outcomes. Conclusions Current evidence suggests that VNS may modulate pulmonary inflammatory responses in preclinical models. However, clinical evidence remains limited and heterogeneous, particularly regarding autonomic and respiratory outcomes. Well-designed clinical trials using standardized stimulation protocols and predefined respiratory end points are needed to clarify its therapeutic potential in respiratory disorders.Keywords
This publication has 29 references indexed in Scilit:
- Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 PatientsFrontiers in Physiology, 2022
- Vagus Nerve Stimulation Attenuates Acute Skeletal Muscle Injury Induced by Hepatic Ischemia/Reperfusion Injury in RatsFrontiers in Pharmacology, 2022
- Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System DiseasesInternational Journal of Molecular Sciences, 2021
- Activation of vagovagal reflex prevents hepatic ischaemia–reperfusion‐induced lung injury via anti‐inflammatory and antioxidant effectsExperimental Physiology, 2021
- Hypercapnic ventilatory response in epilepsy patients treated with VNS: A case‐control studyEpilepsia, 2021
- Vagus nerve stimulation enhances the cholinergic anti-inflammatory pathway to reduce lung injury in acute respiratory distress syndrome via STAT3Cell Death Discovery, 2021
- Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel DiseasesFrontiers in Neuroscience, 2021
- The Role of α7nAChR-Mediated Cholinergic Anti-inflammatory Pathway in Immune CellsInflammation, 2021
- Global Burden of Chronic Respiratory DiseasesJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2020
- Critical Review of Transcutaneous Vagus Nerve Stimulation: Challenges for Translation to Clinical PracticeFrontiers in Neuroscience, 2020